MedTrace Logo

Use of New Antibiotics in Sweden

NCT05048693 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2024-06-18

No results posted yet for this study

Summary

Antibiotic resistance is a growing global health problem of great concern, especially multidrug-resistant Gram-negative bacteria. In recent years some new antibiotics targeting these bacteria have been developed. The aim of this study is to investigate how these new antibiotics are used in Sweden. Information will be collected on patients, types of infections, dosing strategies, treatment outcome and occurrence of antibiotic resistance during treatment. The overall goal is to increase the knowledge about how these antibiotics are prescribed and how to optimize the use of them in clinical practice.

Conditions

  • Multi-antibiotic Resistance

Sponsors & Collaborators

  • Karolinska University Hospital

    collaborator OTHER

  • Sahlgrenska University Hospital

    collaborator OTHER

  • University Hospital, Linkoeping

    collaborator OTHER

  • Skane University Hospital

    collaborator OTHER

  • University Hospital, Umeå

    collaborator OTHER

  • Örebro University, Sweden

    collaborator OTHER

  • Uppsala University

    lead OTHER

Principal Investigators

  • Thomas Tängdén, MD, Phd · Uppsala University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2023-12-30
Completion
2023-12-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05048693 on ClinicalTrials.gov